跳至主要内容
临床试验/NCT00641264
NCT00641264已完成4 期

Laryngopharyngeal Reflux Health Related Quality of Life (LPR-HRQL) Questionnaire Development and Psychometric Testing in Patients Receiving Omeprazole 20 mg Bid as Treatment for Laryngopharyngeal Reflux.

AstraZeneca0 个研究点目标入组 90 人开始时间: 2001年5月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
AstraZeneca
入组人数
90
主要终点
LPR-HRQL questionnaire, which measured symptom distress and the effects of LPR on voice, cough, throat clearing, swallow , and overall impact of acid reflux

研究概览

简要总结

The primary purpose of this study was to establish the psychometric properties of a new disease specific Quality of Life questionnaire, the LPR-HRQL. The specific properties of the questionnaire that were evaluated were: validity, reliability, and responsiveness to change (as a measure of treatment effect).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • New Laryngopharyngeal reflux diagnosis less than 1 month or relapsed patients not under current treatment

排除标准

  • Unable to comply with study requirements.

结局指标

主要结局

LPR-HRQL questionnaire, which measured symptom distress and the effects of LPR on voice, cough, throat clearing, swallow , and overall impact of acid reflux

时间窗: 2 monthly

次要结局

  • Safety assessments via adverse event recording and physical examinations(2 monthly)

研究者

发起方
AstraZeneca
申办方类型
Industry

相似试验